PRECLINICAL STUDY
The Role of Platelet-Derived Growth Factor Signaling in Healing Myocardial Infarcts
Pawel Zymek, MD*,
Marcin Bujak, MD*,
Khaled Chatila, MD*,
Anna Cieslak, MS*,
Geeta Thakker, PhD ,
Mark L. Entman, MD, FACC* and
Nikolaos G. Frangogiannis, MD, FACC*,*
* Section of Cardiovascular Sciences
Section of Atherosclerosis, the DeBakey Heart Center, Baylor College of Medicine, and the Methodist Hospital, Houston, Texas
Manuscript received June 1, 2006;
revised manuscript received July 13, 2006,
accepted July 17, 2006.
* Reprint requests and correspondence: Dr. Nikolaos G. Frangogiannis, Section of Cardiovascular Sciences, One Baylor Plaza, M/S F-602, Baylor College of Medicine, Houston, Texas 77030 (Email: ngf{at}bcm.tmc.edu).
OBJECTIVES: This study sought to examine the role of platelet-derived growth factor (PDGF) signaling in healing myocardial infarcts.
BACKGROUND: Platelet-derived growth factor isoforms exert potent fibrogenic effects through interactions with PDGF receptor (PDGFR)- and PDGFR-ß. In addition, PDGFR-ß signaling mediates coating of developing vessels with mural cells, leading to the formation of a mature vasculature. We hypothesized that PDGFR activation may regulate fibrosis and vascular maturation in healing myocardial infarcts.
METHODS: Mice undergoing reperfused infarction protocols were injected daily with a neutralizing antiPDGFR-ß antibody (APB5), an anti-PDGFR- antibody (APA5), or control immunoglobulin G, and were killed after 7 days of reperfusion.
RESULTS: The PDGF-B, PDGFR- , and PDGFR-ß mRNA expression was induced in reperfused mouse infarcts. Perivascular cells expressing phosphorylated PDGFR-ß were identified in the infarct after 7 days of reperfusion, indicating activation of the PDGF-BB/PDGFR-ß pathway. The PDGFR-ß blockade resulted in impaired maturation of the infarct vasculature, enhanced capillary density, and formation of dilated uncoated vessels. Defective vascular maturation in antibody-treated mice was associated with increased and prolonged extravasation of red blood cells and monocyte/macrophages, suggesting increased permeability. These defects resulted in decreased collagen content in the healing infarct. In contrast, PDGFR- inhibition did not affect vascular maturation, but significantly decreased collagen deposition in the infarct.
CONCLUSIONS: Platelet-derived growth factor signaling critically regulates postinfarction repair. Both PDGFR-ß and PDGFR- mediated pathways promote collagen deposition in the infarct. Activation of PDGF-B/PDGFR-ß is also involved in recruitment of mural cells by neovessels, regulating maturation of the infarct vasculature. Acquisition of a mural coat and maturation of the vasculature promotes resolution of inflammation and stabilization of the scar.
|
Abbreviations and Acronyms
| APA = antiPDGFR- antibody | | APB = antiPDGFR-ß antibody | | IgG = immunoglobulin G | | PCR = polymerase chain reaction | | PDGF = platelet-derived growth factor | | PDGFR = platelet-derived growth factor receptor | | SMA = smooth muscle actin |
|
This article has been cited by other articles:

|
 |

|
 |
 
N. G. Frangogiannis
Regulation of the Inflammatory Response in Cardiac Repair
Circ. Res.,
January 6, 2012;
110(1):
159 - 173.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Katare, F. Riu, K. Mitchell, M. Gubernator, P. Campagnolo, Y. Cui, O. Fortunato, E. Avolio, D. Cesselli, A. P. Beltrami, et al.
Transplantation of Human Pericyte Progenitor Cells Improves the Repair of Infarcted Heart Through Activation of an Angiogenic Program Involving Micro-RNA-132
Circ. Res.,
September 30, 2011;
109(8):
894 - 906.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. B. Osherov, L. Gotha, A. N. Cheema, B. Qiang, and B. H. Strauss
Proteins mediating collagen biosynthesis and accumulation in arterial repair: novel targets for anti-restenosis therapy
Cardiovasc Res,
July 1, 2011;
91(1):
16 - 26.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Kupatt, R. Hinkel, A. Pfosser, C. El-Aouni, A. Wuchrer, A. Fritz, F. Globisch, M. Thormann, J. Horstkotte, C. Lebherz, et al.
Cotransfection of Vascular Endothelial Growth Factor-A and Platelet-Derived Growth Factor-B Via Recombinant Adeno-Associated Virus Resolves Chronic Ischemic Malperfusion: Role of Vessel Maturation
J. Am. Coll. Cardiol.,
July 27, 2010;
56(5):
414 - 422.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Winter, A. A.M. van Oorschot, B. Hogers, L. M. van der Graaf, P. A. Doevendans, R. E. Poelmann, D. E. Atsma, A. C. Gittenberger-de Groot, and M. J. Goumans
A New Direction for Cardiac Regeneration Therapy: Application of Synergistically Acting Epicardium-Derived Cells and Cardiomyocyte Progenitor Cells
Circ Heart Fail,
November 1, 2009;
2(6):
643 - 653.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Lange, J. Heger, G. Euler, M. Wartenberg, H. M. Piper, and H. Sauer
Platelet-derived growth factor BB stimulates vasculogenesis of embryonic stem cell-derived endothelial cells by calcium-mediated generation of reactive oxygen species
Cardiovasc Res,
January 1, 2009;
81(1):
159 - 168.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-X. Chen and A. Stinnett
Ang-1 Gene Therapy Inhibits Hypoxia-Inducible Factor-1{alpha} (HIF-1{alpha})-Prolyl-4-Hydroxylase-2, Stabilizes HIF-1{alpha} Expression, and Normalizes Immature Vasculature in db/db Mice
Diabetes,
December 1, 2008;
57(12):
3335 - 3343.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-X. Chen and A. Stinnett
Disruption of Ang-1/Tie-2 Signaling Contributes to the Impaired Myocardial Vascular Maturation and Angiogenesis in Type II Diabetic Mice
Arterioscler Thromb Vasc Biol,
September 1, 2008;
28(9):
1606 - 1613.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Andrae, R. Gallini, and C. Betsholtz
Role of platelet-derived growth factors in physiology and medicine
Genes & Dev.,
May 15, 2008;
22(10):
1276 - 1312.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bujak, H. J. Kweon, K. Chatila, N. Li, G. Taffet, and N. G. Frangogiannis
Aging-Related Defects Are Associated With Adverse Cardiac Remodeling in a Mouse Model of Reperfused Myocardial Infarction
J. Am. Coll. Cardiol.,
April 8, 2008;
51(14):
1384 - 1392.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|